Delays out of CHM's control, the whole sector is affected, no blame on CHM. The bright side is the low sp. Those who are patient will make a fortune here over the coming years, financial foundation is built now, not when sp hits the $ range.
Great to see there is progress, let's hope for first patient dosed soon. Soon the worldwide CD19 success story will add the CD17-CDH17 success story to it.
GLTA
Ann: Completion of Viral Vector Manufacturing for Phase 1 trial, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.747M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $27.16K | 8.958M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 66853948 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 94845096 | 28 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |